STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. NWBO
  4. [EFFECT] NORTHWEST BIOTHERAPEUTICS INC SEC Filing

[EFFECT] NORTHWEST BIOTHERAPEUTICS INC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 25, 2025 4:00 P.M.
Form: S-3
CIK: 0001072379
Company Name: NORTHWEST BIOTHERAPEUTICS INC
File Number: 333-291044

Source: View Original Filing on SEC EDGAR

Stock NWBO logo
Northwest Bio

OTC:NWBO

NWBO Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

NWBO Latest News

Nov 20, 2025
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
Oct 24, 2025
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
Aug 27, 2025
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Aug 18, 2025
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
Jun 11, 2025
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments

NWBO Latest SEC Filings

Nov 28, 2025
[DEF 14A] NORTHWEST BIOTHERAPEUTICS INC Definitive Proxy Statement
Nov 25, 2025
[424B5] NORTHWEST BIOTHERAPEUTICS INC Prospectus Supplement (Debt Securities)
Nov 20, 2025
[8-K] NORTHWEST BIOTHERAPEUTICS INC Reports Material Event
Nov 14, 2025
[10-Q] NORTHWEST BIOTHERAPEUTICS INC Quarterly Earnings Report
Oct 31, 2025
[8-K] NORTHWEST BIOTHERAPEUTICS INC Reports Material Event

NWBO Stock Data

370.59M
1.49B
7.3%
0.05%
11.34%
Biotechnology
Healthcare
Link
United States
Bethesda